[1]
S. K. Nayak, G. L. Khatik, R. Narang, and H. K. Chopra, “DESIGN AND ANTICANCER ACTIVITY PREDICTION OF DIHYROPYRIMIDINONE BASED NOVEL INHIBITORS OF P53-MDM2 INTERACTION”, Asian J Pharm Clin Res, vol. 10, no. 16, pp. 110–116, Sep. 2017.